Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CH2O2 |
| Molecular Weight | 46.0254 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC=O
InChI
InChIKey=BDAGIHXWWSANSR-UHFFFAOYSA-N
InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)
| Molecular Formula | CH2O2 |
| Molecular Weight | 46.0254 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Formic acid is the simplest carboxylic acid. In nature, formic acid is found in the stings and bites of many insects of the order Hymenoptera, including bees and ants. The principal use of formic acid is as a preservative and antibacterial agent in livestock feed. When sprayed on fresh hay or other silage, it arrests certain decay processes and causes the feed to retain its nutritive value longer. In medicine 85% formic acid application is a safe, economical, and effective alternative in the treatment of common warts with few side-effects and good compliance.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL613777 Sources: https://www.ncbi.nlm.nih.gov/pubmed/4798421 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | EndWarts PEN Approved UseEndWarts PEN is a unique and effective wart treatment |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Controlled proteolysis of amelogenins reveals exposure of both carboxy- and amino-terminal regions. | 2001-06 |
|
| Crystal structure of activated CheY. Comparison with other activated receiver domains. | 2001-05-11 |
|
| Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. | 2001-05 |
|
| Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. | 2001-05 |
|
| Targeting of calsequestrin to the sarcoplasmic reticulum of skeletal muscle upon deletion of its glycosylation site. | 2001-04-15 |
|
| Functional proteins from a random-sequence library. | 2001-04-05 |
|
| Long-lived glycosyl-enzyme intermediate mimic produced by formate re-activation of a mutant endoglucanase lacking its catalytic nucleophile. | 2001-04-01 |
|
| Folding units in calcium vector protein of amphioxus: Structural and functional properties of its amino- and carboxy-terminal halves. | 2001-04 |
|
| Co-oximetry interference by hemoglobin-based blood substitutes. | 2001-04 |
|
| Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. | 2001-04 |
|
| Growth kinetics, diffraction properties and effect of agarose on the stability of a novel crystal form of Thermus thermophilus aspartyl-tRNA synthetase-1. | 2001-04 |
|
| Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. | 2001-04 |
|
| Influence of particle size in the effect of polyethylene on human osteoblastic cells. | 2001-04 |
|
| SuperStar: improved knowledge-based interaction fields for protein binding sites. | 2001-03-30 |
|
| Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. | 2001-03-26 |
|
| Blockade of lactate transport exacerbates delayed neuronal damage in a rat model of cerebral ischemia. | 2001-03-23 |
|
| Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. | 2001-03-16 |
|
| The hydH/G Genes from Escherichia coli code for a zinc and lead responsive two-component regulatory system. | 2001-03-16 |
|
| Extracellular carbonic anhydrase activity facilitates lactic acid transport in rat skeletal muscle fibres. | 2001-03-15 |
|
| NAD/NADH models with axial/central chiralities: superiority of the quinoline ring system. | 2001-03-09 |
|
| Topology of the Na(+)/dicarboxylate cotransporter: the N-terminus and hydrophilic loop 4 are located intracellularly. | 2001-03-09 |
|
| Unusually short distances between the carbonyl oxygen and the tin atom in RCOSMR'3 (M = Ge, Sn, Pb): the importance of intramolecular n(O) --> sigma*(MS) orbital interactions. | 2001-03-08 |
|
| Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry. | 2001-03-05 |
|
| Conserved amino acids near the carboxy terminus of bacterial tyrosyl-tRNA synthetase are involved in tRNA and Tyr-AMP binding. | 2001-03-02 |
|
| Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. | 2001-03-01 |
|
| SCO-spondin, a glycoprotein of the subcommissural organ/Reissner's fiber complex: evidence of a potent activity on neuronal development in primary cell cultures. | 2001-03-01 |
|
| Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients. | 2001-03 |
|
| A novel type II cytokeratin, mK6irs, is expressed in the Huxley and Henle layers of the mouse inner root sheath. | 2001-03 |
|
| Ultrasonic irradiation of dichlorvos: decomposition mechanism. | 2001-03 |
|
| Molecular comparison of the dense granule proteins GRA6 and GRA7 of Neospora hughesi and Neospora caninum. | 2001-03 |
|
| Crystallization and preliminary X-ray crystallographic analysis of RNase HIII from Bacillus subtilis. | 2001-03 |
|
| Purification and crystallization of the human RXRalpha ligand-binding domain-9-cisRA complex. | 2001-03 |
|
| Structure of the M148Q mutant of rusticyanin at 1.5 A: a model for the copper site of stellacyanin. | 2001-03 |
|
| Three-dimensional structure of human follicle-stimulating hormone. | 2001-03 |
|
| Differential recovery of retinal function after mitochondrial inhibition by methanol intoxication. | 2001-03 |
|
| Synthesis, crystal structure, spectral studies, and catechol oxidase activity of trigonal bipyramidal Cu(II) complexes derived from a tetradentate diamide bisbenzimidazole ligand. | 2001-02-26 |
|
| Laboratory study on the high-temperature capture of HCl gas by dry-injection of calcium-based sorbents. | 2001-02-24 |
|
| Formate species in the low-temperature oxidation of dimethyl ether. | 2001-02-24 |
|
| Exchange coupling in carboxylato-bridged dinuclear copper(II) compounds: a density functional study. | 2001-02-02 |
|
| A comparison of salts for the crystallization of macromolecules. | 2001-02 |
|
| Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites. | 2001-02 |
|
| Synthesis and biological evaluation of 2-(3'-(1H-tetrazol-5-yl) bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 receptor antagonist. | 2001-02 |
|
| Conformational preferences of heterochiral peptides. Crystal structures of heterochiral peptides Boc-(D) Val-(D) Ala-Leu-Ala-OMe and Boc-Val-Ala-Leu-(D) Ala-OMe--enhanced stability of beta-sheet through C-H...O hydrogen bonds. | 2001-02 |
|
| Papain does not cleave operator-bound lambda repressor: structural characterization of the carboxy terminal domain and the hinge. | 2001-02 |
|
| [Radiolytic oxidation of tamoxifen with the free radicals OH- and/or HO2-]. | 2001-02 |
|
| Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. | 2001-02 |
|
| The Streptomyces venezuelae pikAV gene contains a transcription unit essential for expression of enzymes involved in glycosylation of narbonolide and 10-deoxymethynolide. | 2001-01-24 |
|
| Solution structure and backbone dynamics of the DNA-binding domain of mouse Sox-5. | 2001-01 |
|
| The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro. | 2001-01 |
|
| Biodegradation of ethyl t-butyl ether (ETBE), methyl t-butyl ether (MTBE) and t-amyl methyl ether (TAME) by Gordonia terrae. | 2001-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11589750
Fifty patients received 85% formic acid application using a topical application/needle puncture technique every other day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25793624
The adapted Aureobasidium pullulans strain could grow under the stress of 0.5 g/L furfural, 3 g/L HMF, 2g/L acetic acid, and 0.5 g/L formic acid, whereas the wild type did not.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:46:31 GMT 2025
by
admin
on
Mon Mar 31 17:46:31 GMT 2025
|
| Record UNII |
0YIW783RG1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
FORMIC ACID
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
VARROMED [AUTHORIZED]
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
DSLD |
4255 (Number of products:2)
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
WHO-VATC |
QP53AG01
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
EPA PESTICIDE CODE |
214900
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
CFR |
21 CFR 186.1316
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB01942
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
1646
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
15740
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
0YIW783RG1
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
SUB13916MIG
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
0YIW783RG1
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
1
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
DTXSID2024115
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
1283200
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
100000078507
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
C83719
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
284
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
m5539
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
C030544
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
30751
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
FORMIC ACID
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
64-18-6
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
52343
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
4537
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
200-579-1
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
PRIMARY | |||
|
1362748
Created by
admin on Mon Mar 31 17:46:31 GMT 2025 , Edited by admin on Mon Mar 31 17:46:31 GMT 2025
|
ALTERNATIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|